Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoulSynergy is a biotechnology company specializing in the development and commercialization of advanced liposomal delivery systems for nutraceuticals and health supplements. The company utilizes pharmaceutical-grade encapsulation technology to significantly enhance the bioavailability and cellular uptake of essential nutrients, bypassing traditional digestive degradation. Their product portfolio includes high-potency liposomal formulations of glutathione, vitamin C, and specialized wellness blends designed for clinical-grade performance. SoulSynergy's solutions are frequently integrated into regenerative medicine protocols, supporting therapies such as stem cell and platelet-rich plasma (PRP) treatments. The company aims to bridge the gap between consumer health products and medical-grade therapeutic delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SoulSynergy.